FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159161014> ?p ?o ?g. }

• W2159161014 endingPage "872" @default.
• W2159161014 startingPage "868" @default.
• W2159161014 abstract "Objective: High-density lipoprotein (HDL) antiatherogenic functions seem to be diminished during inflammatory conditions such as rheumatoid arthritis (RA). The aim of this study was to investigate the effects of tumour necrosis factor (TNF) inhibition on the antioxidative capacity of HDL in RA. Methods: Plasma lipids and paraoxonase (PON-1) activity were investigated in 45 RA patients, before and during 6 months of anti-TNF therapy. In addition, HDL was isolated and tested for its ability to inhibit copper-induced oxidation of low-density lipoprotein in vitro. Results: Plasma HDL concentrations did not change considerably after 6 months of therapy. However, stable increases of PON-1 activities were observed throughout the same period (p<0.03). The increases were more obvious when related to HDL or apolipoprotein AI concentrations. HDL total antioxidative capacity significantly improved 6 months after the initiation of anti-TNF therapy (p = 0.015). The initial improvement of PON-1 activity paralleled a decrease in the inflammatory status, whereas specific TNF blockade was likely to be responsible for the long-term effects. Conclusions: Anti-TNF therapy with infliximab has beneficial effects on lipids through changes in HDL antioxidative capacity, which might be clinically relevant and contribute to the reported protective effect of anti-TNF on cardiovascular morbidity in RA. This emphasises the importance of HDL antiatherogenic capacity for cardiovascular risk in chronic inflammatory conditions." @default.
• W2159161014 created "2016-06-24" @default.
• W2159161014 creator A5001646568 @default.
• W2159161014 creator A5027955775 @default.
• W2159161014 creator A5032894860 @default.
• W2159161014 creator A5037953937 @default.
• W2159161014 creator A5046171667 @default.
• W2159161014 creator A5062651514 @default.
• W2159161014 creator A5075096995 @default.
• W2159161014 creator A5075230176 @default.
• W2159161014 creator A5076200839 @default.
• W2159161014 creator A5076651742 @default.
• W2159161014 date "2008-07-17" @default.
• W2159161014 modified "2023-10-16" @default.
• W2159161014 title "Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients" @default.
• W2159161014 cites W1515255326 @default.
• W2159161014 cites W1891655359 @default.
• W2159161014 cites W1922240609 @default.
• W2159161014 cites W1976525661 @default.
• W2159161014 cites W1978455413 @default.
• W2159161014 cites W1997363583 @default.
• W2159161014 cites W2003508016 @default.
• W2159161014 cites W2006809944 @default.
• W2159161014 cites W2015022121 @default.
• W2159161014 cites W2016645249 @default.
• W2159161014 cites W2045622064 @default.
• W2159161014 cites W2053802334 @default.
• W2159161014 cites W2077727404 @default.
• W2159161014 cites W2099065288 @default.
• W2159161014 cites W2113209574 @default.
• W2159161014 cites W2131872763 @default.
• W2159161014 cites W2150278133 @default.
• W2159161014 cites W2153797344 @default.
• W2159161014 cites W2170874916 @default.
• W2159161014 cites W2330503938 @default.
• W2159161014 cites W2337469201 @default.
• W2159161014 cites W65358577 @default.
• W2159161014 doi "https://doi.org/10.1136/ard.2008.092171" @default.
• W2159161014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18635596" @default.
• W2159161014 hasPublicationYear "2008" @default.
• W2159161014 type Work @default.
• W2159161014 sameAs 2159161014 @default.
• W2159161014 citedByCount "113" @default.
• W2159161014 countsByYear W21591610142012 @default.
• W2159161014 countsByYear W21591610142013 @default.
• W2159161014 countsByYear W21591610142014 @default.
• W2159161014 countsByYear W21591610142015 @default.
• W2159161014 countsByYear W21591610142016 @default.
• W2159161014 countsByYear W21591610142017 @default.
• W2159161014 countsByYear W21591610142018 @default.
• W2159161014 countsByYear W21591610142019 @default.
• W2159161014 countsByYear W21591610142020 @default.
• W2159161014 countsByYear W21591610142021 @default.
• W2159161014 countsByYear W21591610142022 @default.
• W2159161014 countsByYear W21591610142023 @default.
• W2159161014 crossrefType "journal-article" @default.
• W2159161014 hasAuthorship W2159161014A5001646568 @default.
• W2159161014 hasAuthorship W2159161014A5027955775 @default.
• W2159161014 hasAuthorship W2159161014A5032894860 @default.
• W2159161014 hasAuthorship W2159161014A5037953937 @default.
• W2159161014 hasAuthorship W2159161014A5046171667 @default.
• W2159161014 hasAuthorship W2159161014A5062651514 @default.
• W2159161014 hasAuthorship W2159161014A5075096995 @default.
• W2159161014 hasAuthorship W2159161014A5075230176 @default.
• W2159161014 hasAuthorship W2159161014A5076200839 @default.
• W2159161014 hasAuthorship W2159161014A5076651742 @default.
• W2159161014 hasConcept C104317684 @default.
• W2159161014 hasConcept C126322002 @default.
• W2159161014 hasConcept C134018914 @default.
• W2159161014 hasConcept C135763542 @default.
• W2159161014 hasConcept C17991360 @default.
• W2159161014 hasConcept C185592680 @default.
• W2159161014 hasConcept C203014093 @default.
• W2159161014 hasConcept C2776151105 @default.
• W2159161014 hasConcept C2776509667 @default.
• W2159161014 hasConcept C2777077863 @default.
• W2159161014 hasConcept C2777138892 @default.
• W2159161014 hasConcept C2777575956 @default.
• W2159161014 hasConcept C2778163477 @default.
• W2159161014 hasConcept C2778242859 @default.
• W2159161014 hasConcept C2780072125 @default.
• W2159161014 hasConcept C2780541478 @default.
• W2159161014 hasConcept C37501387 @default.
• W2159161014 hasConcept C55493867 @default.
• W2159161014 hasConcept C62746215 @default.
• W2159161014 hasConcept C71924100 @default.
• W2159161014 hasConcept C98274493 @default.
• W2159161014 hasConceptScore W2159161014C104317684 @default.
• W2159161014 hasConceptScore W2159161014C126322002 @default.
• W2159161014 hasConceptScore W2159161014C134018914 @default.
• W2159161014 hasConceptScore W2159161014C135763542 @default.
• W2159161014 hasConceptScore W2159161014C17991360 @default.
• W2159161014 hasConceptScore W2159161014C185592680 @default.
• W2159161014 hasConceptScore W2159161014C203014093 @default.
• W2159161014 hasConceptScore W2159161014C2776151105 @default.
• W2159161014 hasConceptScore W2159161014C2776509667 @default.
• W2159161014 hasConceptScore W2159161014C2777077863 @default.
• W2159161014 hasConceptScore W2159161014C2777138892 @default.

• next